Follow the people · Insider

JW

James N. Wilson

Insider · Director · CORT

James N. Wilson files insider transactions with the SEC as a director of Corcept Therapeutics (CORT). We hold 3 disclosed purchases and sales filed since 27 January 2006, 3 of them in the last 90 days.

  • Files forCORT
  • Disclosed buys and sells3 in all, 3 in the last 90 days
  • Last disclosure18 August 2026

Positions held

2 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 15 December 200614 August 2026Director · Corcept Therapeutics (CORT)185 Form 4 lines · source: SEC Form 4
  • Filed 4 October 20053 April 2009Director · Amylin Pharmaceuticals (AMLN)31 Form 4 lines · source: SEC Form 4

Everything they disclosed

120 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.